Published in Lab Law Weekly, June 23rd, 2006
According to the review, "Documenting an experiment in a way that ensures that the record can act as evidence to support a patent claim or to demonstrate compliance with the U.S. Food and Drug Administration's (FDA's) predicate rules puts demands on an electronic laboratory notebook (ELN) that are not trivial. The 1996 General Agreement on Tariffs and Trade (GATT) allowed notebook records that were generated outside of the U.S. to be used to claim precedence in U.S. patent claims. This agreement spurred interest in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.